Dal Yoo

1.1k total citations
21 papers, 828 citations indexed

About

Dal Yoo is a scholar working on Surgery, Emergency Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dal Yoo has authored 21 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Emergency Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dal Yoo's work include Intraperitoneal and Appendiceal Malignancies (12 papers), Appendicitis Diagnosis and Management (8 papers) and Ovarian cancer diagnosis and treatment (6 papers). Dal Yoo is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (12 papers), Appendicitis Diagnosis and Management (8 papers) and Ovarian cancer diagnosis and treatment (6 papers). Dal Yoo collaborates with scholars based in United States, Mexico and Germany. Dal Yoo's co-authors include Paul H. Sugarbaker, O. Anthony Stuart, Tristan D. Yan, Pierre Marchettini, Lawrence S. Lessin, Lana Bijelić, David Chang, Faheez Mohamed, Yaïr I. Z. Acherman and Santiago González‐Moreno and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Clinical Infectious Diseases.

In The Last Decade

Dal Yoo

21 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dal Yoo United States 15 531 302 259 239 83 21 828
Tatiana Beresnev United States 12 478 0.9× 196 0.6× 329 1.3× 142 0.6× 161 1.9× 16 853
Mark Adelson United States 16 856 1.6× 114 0.4× 176 0.7× 1.2k 4.9× 321 3.9× 45 1.9k
Akash Mehta United Kingdom 17 409 0.8× 237 0.8× 83 0.3× 175 0.7× 190 2.3× 33 813
Ryuichi Hamazoe Japan 13 556 1.0× 126 0.4× 363 1.4× 208 0.9× 152 1.8× 61 961
Namrata Setia United States 15 378 0.7× 53 0.2× 362 1.4× 52 0.2× 319 3.8× 67 880
R. Barakat United States 19 692 1.3× 45 0.1× 159 0.6× 842 3.5× 351 4.2× 47 1.3k
A H Qizilbash Canada 15 418 0.8× 72 0.2× 85 0.3× 56 0.2× 174 2.1× 31 677
Nine van der Vange Netherlands 14 367 0.7× 81 0.3× 67 0.3× 234 1.0× 141 1.7× 23 836
Bradley R. Hall United States 12 320 0.6× 135 0.4× 131 0.5× 67 0.3× 244 2.9× 29 723
Vignesh Narasimhan Australia 13 279 0.5× 124 0.4× 69 0.3× 84 0.4× 228 2.7× 49 548

Countries citing papers authored by Dal Yoo

Since Specialization
Citations

This map shows the geographic impact of Dal Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dal Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dal Yoo more than expected).

Fields of papers citing papers by Dal Yoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dal Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dal Yoo. The network helps show where Dal Yoo may publish in the future.

Co-authorship network of co-authors of Dal Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Dal Yoo. A scholar is included among the top collaborators of Dal Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dal Yoo. Dal Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugarbaker, Paul H., Lana Bijelić, David Chang, & Dal Yoo. (2010). Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. Journal of Surgical Oncology. 102(6). 576–581. 75 indexed citations
2.
Haase, Erika, Dal Yoo, & Paul H. Sugarbaker. (2009). Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World Journal of Surgical Oncology. 7(1). 48–48. 19 indexed citations
3.
Yoo, Dal, et al.. (2009). Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer. Recent Patents on Anti-Cancer Drug Discovery. 4(2). 174–179. 13 indexed citations
4.
Yan, Tristan D., Dal Yoo, & Paul H. Sugarbaker. (2006). Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. European Journal of Surgical Oncology. 32(9). 948–953. 59 indexed citations
5.
Sugarbaker, Paul H., Tristan D. Yan, O. Anthony Stuart, & Dal Yoo. (2006). Comprehensive management of diffuse malignant peritoneal mesothelioma. European Journal of Surgical Oncology. 32(6). 686–691. 93 indexed citations
6.
Yan, Tristan D., O. Anthony Stuart, Dal Yoo, & Paul H. Sugarbaker. (2006). Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. Journal of Translational Medicine. 4(1). 17–17. 21 indexed citations
7.
Song, Seung‐Hun, et al.. (2006). Fluoroscopy-Assisted Retroperitoneal Laparoscopic Renal Surgery in Children. Journal of Endourology. 20(4). 256–259. 4 indexed citations
8.
Sugarbaker, Paul H., et al.. (2005). Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy. The Oncologist. 10(2). 112–122. 142 indexed citations
9.
Sugarbaker, Paul H., O. Anthony Stuart, & Dal Yoo. (2005). Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy. Journal of Oncology Pharmacy Practice. 11(3). 111–119. 27 indexed citations
10.
Mohamed, Faheez, Pierre Marchettini, O. Anthony Stuart, Dal Yoo, & Paul H. Sugarbaker. (2003). A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. European Journal of Surgical Oncology. 29(3). 261–265. 35 indexed citations
11.
Sugarbaker, Paul H., Yaïr I. Z. Acherman, Santiago González‐Moreno, et al.. (2002). Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Seminars in Oncology. 29(1). 51–61. 91 indexed citations
12.
Marchettini, Pierre, Anthony J. Stuart, Faheez Mohamed, Dal Yoo, & Paul H. Sugarbaker. (2002). Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemotherapy and Pharmacology. 49(6). 499–503. 63 indexed citations
13.
Schnake, Klaus John, Paul H. Sugarbaker, & Dal Yoo. (1999). Neutropenia following Perioperative Intraperitoneal Chemotherapy. Tumori Journal. 85(1). 41–46. 20 indexed citations
14.
Yoo, Dal & Lawrence S. Lessin. (1992). Drug-associated “bite cell” hemolytic anemia. The American Journal of Medicine. 92(3). 243–248. 11 indexed citations
15.
Yoo, Dal. (1991). Who Should be the Medical Director of a Hospice Program?. Journal of Palliative Care. 7(2). 37–38. 1 indexed citations
17.
Yoo, Dal, Lawrence E. Pierce, & Lawrence S. Lessin. (1983). Acquired pure red cell aplasia associated with chronic lymphocytic leukemia. Cancer. 51(5). 844–850. 13 indexed citations
18.
Yoo, Dal, Henri B. Weems, & Lawrence S. Lessin. (1982). Platelet to Leukocyte Adherence Phenomena. Acta Haematologica. 68(2). 142–148. 12 indexed citations
19.
Yoo, Dal, et al.. (1980). Myeloproliferative syndrome with sideroblastic anemia and acquired hemoglobin H disease. Cancer. 45(1). 78–83. 23 indexed citations
20.
Yoo, Dal, et al.. (1978). Bone-Marrow Mast Cells in Lymphoproliferative Disorders. Annals of Internal Medicine. 88(6). 753–757. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026